WVE – wave life sciences ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
Arrowhead Pharmaceuticals: Important Catalysts And Some Challenges Ahead [Seeking Alpha]
Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning [Yahoo! Finance]
WAVE Life Sciences Ltd (WVE) Q3 2025 Earnings Call Highlights: Promising Clinical Advances and ... [Yahoo! Finance]
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Wedbush from $18.00 to $20.00. They now have an "outperform" rating on the stock.
WAVE Life Sciences (NASDAQ:WVE) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $16.00. They now have an "overweight" rating on the stock.
Form 8-K Wave Life Sciences Ltd. For: Nov 17
Form 4 Wave Life Sciences Ltd. For: Nov 13 Filed by: Rawcliffe Adrian
Form 4 Wave Life Sciences Ltd. For: Nov 13 Filed by: Kolchinsky Peter
Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Form S-8 Wave Life Sciences Ltd.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.